Article Listing - FDA approves non-CFC asthma inhalers using Zephex 134a
US OTC DRUGMAKERS A TAKEOVER TARGET
17 February 1992
The value of over-the-counter medicine franchises will continue to rise and as a result smaller OTC drugmakers (such as Carter...
MOROCCO BANS GLAFENINE
10 February 1992
Morocco is the latest country to ban marketing of Roussel Uclaf's glafenine-based analgesic products Adalgur, Glifanan and Myantal. A...
SALMON CALCITONIN ASSAY FROM CORTECS
10 February 1992
UK company Cortecs Diag-nostics has developed an enzyme immunoassay for salmon calcitonin which employs an improvement on procedural format with...
H2 BLOCKERS FOR RHINITIS?
10 February 1992
The possibility that histamine H2 receptor blockers may be useful as a treatment for individuals with rhinitis has been raised...
B-MS SCHOOL OF PUBLIC HEALTH
10 February 1992
US concern Bristol-Myers Squibb is to fund its school of public health for a period of five years to the...
GERMAN DRUG CONSUMPTION
10 February 1992
Klaus Stuerzbecher, president of the German federation of pharmacists, the ABDA, has said that a new ABDA study shows that,...
FRENCH HEALTH SPENDING SURPLUS
10 February 1992
The French social security budget is expecting to post a deficit of only 2 billion French francs ($364.3 million), this...
APPROVAL SETBACK FOR US BIOSCIENCE
10 February 1992
The US Food and Drug Administra-tion's Oncologic Drugs Advisory Committee has declined to recommend marketing approval of US Biosci-ence Inc's...
US APPROVAL FOR WELLCOME'S MIVACRON
10 February 1992
The US Food and Drug Administr-ation has granted marketing approval for Burroughs Wellcome's Mivacron (mivacurium chloride) to be used as...
CORTEX IN STROKE TREATMENT JV
10 February 1992
Two US biotechnology companies have agreed to develop potential treatments for stroke and other acute degenerative brain disorders. Cortex Pharmaceuticals...
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
